Delivery Order SPE2DR25D3201-SPE2DR26FT6AF
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,813.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 8, 2025. This competitively awarded, non-set-aside contract represents a single delivery order for a contrast media pharmaceutical product commonly used in diagnostic imaging procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $3,457.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL, a contrast agent used in medical imaging procedures, with a 100 mL bottle quantity and a completion date of January 20, 2026. The contract, which was competitively awarded with no set-aside designation, leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $3,337.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL, a contrast medium supplied in 100 mL bottles. This non-competitive delivery order, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,750.69 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, with completion scheduled for January 9, 2026. This non-competitive delivery order procures Visipaque 320 mg/ml in 100ml bottles, a contrast agent used in medical imaging procedures. The order is structured as a firm fixed-price delivery order, which is a task order placed against an existing indefinite delivery contract (IDC) with...
- The Defense Logistics Agency awarded a $4,246.40 delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL infusion bottles (150 mL) on September 24, 2025, with completion expected by September 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line-item procurement of this contrast medium...
- The Defense Logistics Agency awarded a $7,589.05 delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Visipaque 320 mg/ml infusion bottles (150ml). This is a firm fixed-price contract with an ultimate completion date of January 23, 2026, and represents a non-set-aside award issued under competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a $7,597.00 delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of November 6, 2025. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,118.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL infusion bottles (150 mL) with an ultimate completion date of January 5, 2026. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,299.90 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed-price contract was issued on January 13, 2026, with a completion date of January 14, 2026, and represents a non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $6,475.92 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...